@peterjwolff · Long LLY

Still bullish $LLY

Nvidia and Eli Lilly are building a $1B lab for AI drug discovery in SF. Lilly CEO Dave Ricks talks about their data advantage: “Some scale [tech-bio] players…are just training on public data but they’re only 4,000 ever approved drugs. Lilly alone has 3 million failed drugs.”

Read asLong LLY

Since the call—

unrankedThe analyst's rank today

High · 0.99Confidence

Wed, Sep 30Tweeted

Thu, Oct 1 closeCounted from

not in the basket todayBasket

Rank per close

—

Oct 1

#480

Oct 4

—

Oct 5

#439

Oct 6

—

Oct 7

—

Oct 8

—

Oct 11

—

Oct 12

—

Oct 13

—

Oct 14

—

Oct 15

—

Oct 18

—

Oct 19